NervGen Pharma Corp. Announces Public Offering
July 22, 2020 16:42 ET
|
NervGen Pharma Corp.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN; OTCQX:...
NervGen Pharma Appoints Dr. Michael Abrams to Board of Directors
September 25, 2018 08:00 ET
|
NervGen Pharma Corp.
VANCOUVER, British Columbia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of...
NervGen Pharma Announces Granting of US Patent for Breakthrough Nerve Regeneration Technology
August 10, 2018 08:00 ET
|
NervGen Pharma Corp.
VANCOUVER, British Columbia, Aug. 10, 2018 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve...
NervGen Pharma Licenses Breakthrough Nerve Regeneration Technology from Case Western Reserve University
July 18, 2018 08:00 ET
|
NervGen Pharma Corp.
VANCOUVER, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen”), in Vancouver, and Case Western Reserve University (“Case Western Reserve”) in Cleveland have entered...